Philip M. Hartigan
Brigham and Women's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Philip M. Hartigan.
Journal of Cardiothoracic and Vascular Anesthesia | 1995
Simon C. Body; Philip M. Hartigan; Stanton K. Shernan; V. Formanek; William E. Hurford
The biologic and therapeutic roles of NO are rapidly being elucidated. Before inhalational NO administration is commonplace, there is a clear need for consensus regarding safe and accurate delivery and measurement systems. The potential for NO usage appears large and potentially life-saving; yet multicenter trials need to carefully evaluate efficacy and safety.
Anesthesiology | 1990
William Camann; Philip M. Hartigan; Lesley I. Gilbertson; Mark D. Johnson; Sanjay Datta
Sixty healthy patients scheduled for elective cesarean delivery under epidural anesthesia were randomized to receive either lidocaine or 2-chloroprocaine as the primary local anesthetic agent. When patients first complained of postoperative pain in the recovery room, they were given either fentanyl 50 micrograms or butorphanol 2 mg, epidurally, in a randomized, blinded fashion. Postoperative analgesia, quantitated on a visual analogue scale, as well as time elapsed until first request for supplemental opioid, did not differ for patients receiving butorphanol after either 2-chloroprocaine or lidocaine anesthesia. In contrast, epidural fentanyl produced a shorter and lesser degree of sensory analgesia after 2-chloroprocaine use, whereas epidural fentanyl after lidocaine anesthesia provided pain relief similar to that seen in the butorphanol groups. Side effects were limited to somnolence with butorphanol and pruritus with fentanyl. No evidence of respiratory depression was seen in any patient. We conclude that 2 mg of butorphanol epidurally provides approximately 2 to 3 h of effective analgesia after cesarean delivery with either lidocaine or 2-chloroprocaine anesthesia. Epidural fentanyl seems to be antagonized when 2-chloroprocaine, but not lidocaine, is used as the primary local anesthetic agent. We suggest a possible mu-receptor-specific etiology for this effect.
Journal of Surgical Oncology | 2015
Ritu R. Gill; Yifan Zheng; Julianne Barlow; Jagadeesan Jayender; Erin Girard; Philip M. Hartigan; Lucian R. Chirieac; Carol J. Belle‐King; Kristen Murray; Christopher Sears; Jon O. Wee; Michael T. Jaklitsch; Yolonda L. Colson; Raphael Bueno
To facilitate localization and resection of small lung nodules, we developed a prospective clinical trial (ClinicalTrials.gov number NCT01847209) for a novel surgical approach which combines placement of fiducials using intra‐operative C‐arm computed tomography (CT) guidance with standard thoracoscopic resection technique using image‐guided video‐assisted thoracoscopic surgery (iVATS).
Anesthesia & Analgesia | 2002
Ka Shun Cheng; Ju-Mei Ng; Hsueh-Yu Li; Philip M. Hartigan
IMPLICATIONS This report describes difficulties encountered in the airway management of six infants with concurrent vallecular cyst and laryngomalacia. It is hoped that our experience will assist others in the management of such patients.
International Anesthesiology Clinics | 2000
Patrick W. Seigne; Philip M. Hartigan; Simon C. Body
The pathophysiology, medical and surgical management of emphysema have been reviewed as a foundation to the physiological goals and principles of anesthetic management of patients with emphysema. An understanding of the cardiovascular and respiratory consequences of emphysema combined with anesthesia, PPV, and thoracic surgery is essential to achieving the challenging physiological goals of providing anesthesia, positive pressure and one-lung ventilation, and postoperative analgesia in a manner consistent with rapid postoperative extubation, hemodynamic stability, adequate gas exchange, and minimal barotrauma for this population of patients.
Anesthesia & Analgesia | 2000
Mauricio Nino; Simon C. Body; Philip M. Hartigan
IMPLICATIONS Using certain specialized endotracheal tubes designed to allow single-lung ventilation for certain thoracic surgical procedures may be fraught with technical difficulties owing to common anatomic anomalies. This case report describes a simple solution for an ill-fitting right double-lumen endotracheal tube using a balloon-tipped catheter.
Anesthesia & Analgesia | 2011
Sarah H. Wiser; Philip M. Hartigan
Aberrant tracheobronchial anatomy is reported at an incidence of approximately 10% and most frequently involves the segmental and subsegmental bronchi. The most relevant abnormality to the practice of anesthesiology is the presence of a tracheal bronchus. Although typically an asymptomatic finding during bronchoscopy, a tracheal bronchus has important implications for airway management and lung isolation. Coexisting abnormalities may further complicate lung isolation. We describe a patient with a tracheal bronchus, coexisting with a left-shifted carina and apically retracted left mainstem bronchus, presenting for right extrapleural pneumonectomy. Attempts to place a left-sided double-lumen endotracheal tube were unsuccessful. We discuss our solution, review the literature, and present potential solutions for lung isolation in patients with a tracheal bronchus.
Current Opinion in Anesthesiology | 2008
Ju-Mei Ng; Philip M. Hartigan
Purpose of review Extrapleural pneumonectomy is a radical and aggressive surgery that presents a great challenge to the thoracic anesthesiologist. This surgery is performed routinely by only a few centers in the world and this review represents our institutions experience in anesthetic care. Recent findings Prominent among the developing multimodal treatment options is the combination of extrapleural pneumonectomy with intraoperative intracavitary hyperthermic chemotherapy. Outcome survival benefits have recently been demonstrated for the less completely cytoreductive pleurectomy procedure when combined with intraoperative intracavitary hyperthermic chemotherapy and trials are well under way for extrapleural pneumonectomy plus intraoperative intracavitary hyperthermic chemotherapy. Anesthetic management of extrapleural pneumonectomy is further impacted by these developments. Summary Anesthetic management importantly contributes to containment of the perioperative complications of extrapleural pneumonectomy. An appreciation of the technical aspects and physiologic disruptions associated with extrapleural pneumonectomy is critical to effective management. While data on this relatively uncommon surgical procedure are scarce, some referral centers have accumulated extensive experience. This review summarizes relevant surgical aspects and anesthetic insights from the Brigham and Womens Hospital experience. Included are the anesthetic implications of intraoperative intracavitary hyperthermic chemotherapy in combination with extrapleural pneumonectomy – an emerging therapeutic option in the treatment of malignant pleural mesothelioma.
A & A Case Reports | 2015
Thomas Edrich; Cristina Pojer; Gerhard Fritsch; Joerg Hutter; Philip M. Hartigan; Ottokar Stundner; Peter Gerner; Marc M. Berger
A patient with an endobronchial tumor and critical airway obstruction developed hypoxia and hypercarbia and, subsequently, cardiac arrest during a palliative laser core-out excision. The differential diagnosis included tension pneumothorax, as well as airway obstruction due to swelling of residual tumor or to blood clots. In this case, empiric needle decompression could have had deleterious consequences. Immediate bedside lung ultrasonography provided real-time information leading to the stabilization of the patient. This case provides compelling motivation for anesthesiologists to acquire this easily learned skill.
Archive | 2012
Peter Gerner; Philip M. Hartigan
Thoracotomy is among the most painful of all surgical incisions. Necessary motions of respiration exacerbate that pain. It is no surprise that the most frequent perioperative complications following thoracic surgery are pulmonary in nature, or that good control of thoracotomy pain improves pulmonary outcome.